Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2024-07-10

EMA Expired: Pixuvri (pixantrone dimaleate) — Les Laboratoires Servier

View source ↗

Summary

The EMA has expired the marketing authorization for Pixuvri (pixantrone dimaleate) by Les Laboratoires Servier, effectively withdrawing its approval for use in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pixuvri (pixantrone dimaleate)

Snippet

Status: Expired. Therapeutic area: Lymphoma, Non-Hodgkin. MAH: Les Laboratoires Servier. Decision date: 09/11/2021